Congratulations to Dr. Emily Largent on her appointment to Division Chief of Medical Ethics effective July 1. Read the full announcement here: medicalethicshealthpolicy.med.upenn.edu/events/in-th...

“Five years after the initial accelerated approval, you should have a definitive answer. Thousands of people are getting those drugs. That seems a mistake if we don’t know whether they work or not," said @zekeemanuel.bsky.socialbit.ly/3xBUZHf

Many cancer drugs remain unproven 5 years after accelerated approval, a study finds

Researchers have found that most cancer drugs granted accelerated approval by the U.S. Food and Drug Administration do not deliver on their early promise.

“The coming trials for the next generation of implantable neurotech devices will likely be a major step forward in producing better patient outcomes," says @annawexler.bsky.socialwww.forbes.com/sites/saibal...

Brain-Computer Interfaces Are Becoming Immensely Popular

Though not a new technology, new advancements have progressed this field significantly.

Reading about how Penn's Master of Health Care Innovation transforms our students' professional lives is one reason I love my work. improvinghealthcare.mehp.upenn.edu/thought-lead...#healthcare#innovation#education#higherEd

#Healthcare#JAMA#Medicaid expansion as a natural experiment, finding that only higher-wage workers (docs, nurses, managers) benefit from improving finances.

I wish it was to talk about better news, but I joined the folks at @statnews.bsky.socialwww.statnews.com/2024/03/14/r...

A dilemma in ALS, the first MASH drug, & why gene therapy is hard

This week on "The Readout LOUD" podcast: What happens when an approved drug doesn't work? Why don't patients want gene therapy? And is MASH still a big deal?

Out today in JAMA, @akesselheim.bsky.socialjamanetwork.com/journals/jam...

FDA in the Crosshairs of Science, Politics, and Abortion

In this Viewpoint, the Supreme Court case FDA v AHM is used to illustrate the tension the FDA faces between science and politics, and state authority over abort

"The system of food labeling in the United States does not make it easy for consumers trying to assess the nutritional value of the foods they buy. Now, the [FDA] can do something about it," writes Christina Roberto and colleagues. @washingtonpost.comwww.washingtonpost.com/opinions/202...

Opinion | These countries are doing nutrition labels the right way

The FDA has a choice to make about nutrition labels. It should not defer to food industry.

Congrats to postdoc Blake Hereth on being awarded the prestigious Alvin Plantinga Prize by @amphilsociety.bsky.socialwww.apaonline.org/news/661003/...

APA announces Fall 2023 prize winners - American Philosophical Association

2023 APA/PDC Prize for Excellence and Innovation in Philosophy Programs: Philosophy Learning and Teaching Organization (PLATO) (Affiliated with the University of Washington)

Higher levels of wealth are associated with increased longevity, but little is known about the impact of wealth redistribution. @atheendar.bsky.socialpubmed.ncbi.nlm.nih.gov/38285594/

Wealth Redistribution to Extend Longevity in the US - PubMed

These findings suggest that wealth inequality in the US is associated with significant inequities in survival. Wealth redistribution policies may substantially reduce those inequities and increase pop...